|
TABLE OF CONTENTS
|
 |
|
|
|
Volume 7, Issue 6 (December 2007) |
 |
In this issue
 In This Issue
Original Articles
Also new
   AOP
|
| This alert is sponsored by |
LESS MOVING TARGET, MORE BULL'S-EYE-Invitrogen™ GPCR research tools
Gain a clear advantage when interrogating difficult receptors with integrated GPCR cellular assays from Invitrogen. The expert tools needed to see the most lucrative targets, including target assays with multiple readout options, are right in front of you. Learn more and sign up for the Drug Discovery E-newsletter at www.invitrogen.com/gpcr. |
|
|
|
|
|
| Advertisement |
|
Neuropsychopharmacology Reviews
Covering Neuroplasticity into 2008
The American College of Neuropsychopharmacology and Nature Publishing Group are pleased to announce the arrival of Neuropsychopharmacology Reviews, a special issue of Neuropsychopharmacology. The inaugural issue will publish in January and cover neuroplasticity with more than twelve in-depth articles, complete with NPG-quality illustrations, in more than 200 pages. This issue is available for single issue purchase, visit www.neuropsychopharmacologyreviews.org to learn more. |
|
|
| |
|
|
|
Articles for The Pharmacogenomics Journal are published online ahead of print through Advance Online Publication (AOP), meaning that the latest research reaches you in the timeliest way possible. Check the AOP homepage each week to make sure that you are not left behind. |
|
|
| |
In This Issue |
Top |
|
In This Issue
Pharmacogenomics J 2007 7: 367; 10.1038/sj.tpj.6500484
Abstract | Full Text |
|
Original Articles |
Top |
|
Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependence
K Xu, T R Anderson, K M Neyer, N Lamparella, G Jenkins, Z Zhou, Q Yuan, M Virkkunen & R H Lipsky
Pharmacogenomics J 2007 7: 368-379; advance online publication, January 2, 2007; 10.1038/sj.tpj.6500430
Abstract | Full Text |
|
|
|
Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans
H Ishiguro, S Iwasaki, L Teasenfitz, S Higuchi, Y Horiuchi, T Saito, T Arinami & E S Onaivi
Pharmacogenomics J 2007 7: 380-385; advance online publication, December 26, 2006; 10.1038/sj.tpj.6500431
Abstract | Full Text |
|
|
|
Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea
Q Ma, D F Wyszynski, J J Farrell, A Kutlar, L A Farrer, C T Baldwin & M H Steinberg
Pharmacogenomics J 2007 7: 386-394; advance online publication, February 13, 2007; 10.1038/sj.tpj.6500433
Abstract | Full Text |
|
|
|
Exploratory aspirin resistance trial in healthy Japanese volunteers (J-ART) using platelet aggregation as a measure of thrombogenicity
T Fujiwara, M Ikeda, K Esumi, T D Fujita, M Kono, H Tokushige, T Hatoyama, T Maeda, T Asai, T Ogawa, T Katsumata, S Sasaki, E Suzuki, M Suzuki, F Hino, T K Fujita, H Zaima, M Shimada, T Sugawara, Y Tsuzuki, Y Hashimoto, H Hishigaki, S Horimoto, N Miyajima, T Yamamoto, K Imagawa, S Sesoko & Y Fujisawa
Pharmacogenomics J 2007 7: 395-403; advance online publication, January 23, 2007; 10.1038/sj.tpj.6500435
Abstract | Full Text |
|
|
|
Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis
M Drozdzik, T Rudas, A Pawlik, W Gornik, M Kurzawski & M Herczynska
Pharmacogenomics J 2007 7: 404-407; advance online publication, February 27, 2007; 10.1038/sj.tpj.6500438
Abstract | Full Text |
|
|
|
Low frequency of CYP2D6 poor metabolizers among schizophrenia patients
A LLerena, P Dorado, E M Peñas-LLedó, M C Cáceres & A De la Rubia
Pharmacogenomics J 2007 7: 408-410; advance online publication, February 27, 2007; 10.1038/sj.tpj.6500439
Abstract | Full Text |
|
|
|
The concentration-dependent effects of ethanol on Caenorhabditis elegans behaviour
P H Mitchell, K Bull, S Glautier, N A Hopper, L Holden-Dye & V O'Connor
Pharmacogenomics J 2007 7: 411-417; advance online publication, February 27, 2007; 10.1038/sj.tpj.6500440
Abstract | Full Text |
|
|
|
Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment
P Molero, F Ortuño, M Zalacain & A Patiño-García
Pharmacogenomics J 2007 7: 418-426; advance online publication, March 13, 2007; 10.1038/sj.tpj.6500441
Abstract | Full Text |
|
|
|
|
|
| Advertisement |
|
|
|
If you are unable to access the articles in this Table of Contents e-alert, your library may not subscribe to The Pharmacogenomics Journal. Library recommendation through our online recommendation form is a simple way to make your librarian aware that this journal is valuable to your research.
Recommend now by visiting http://ealerts.nature.com/cgi-bin24/DM/y/hhpM0T5nzc0Hjp0BTaf0Ep.
|
|
|
| |
|
|
|
|
|
Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription.
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department.
For print subscription enquiries, please contact our subscription department.
For other enquiries, please contact our customer feedback department.
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
© 2007 Nature Publishing Group |
 |
| |
|
|
